InnoPath Therapeutics is developing a platform of transformational topical therapeutics to treat the tens of millions of people who get non-melanoma skin cancer and pre-cancers each year. In contrast to the current standards of care, our novel formulations target the pathways associated with the tumor cells while avoiding painful side effects and preserving overall skin health. We have a dedicated team of scientists, physicians, and business professionals with decades of experience in drug development and more than $1B of exits.